Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Poon

Showing results (1-10 of 252) with videos related to

Pageof 26
Sort By:
Annals of Hematology|January 1, 1994
Long-term surveillance studies of previously untreated and treated patients, virally uninfected and infected patients--impact on the immune and other systemsM C Poon
Journal of the Medical Association of the State of Alabama|June 1, 1979
Evaluation of clotting disordersM C Poon
Transfusion Medicine Reviews|July 1, 1993
Cryoprecipitate: uses and alternativesM C Poon
Current Opinion in Hematology|October 18, 2001
Use of recombinant factor VIIa in hereditary bleeding disordersM C Poon
The Journal of Laboratory and Clinical Medicine|September 1, 1988
Patients with hemophilia B (Christmas disease) who have anti-factor IX: genetic heterogeneityM C Poon
Asia-Pacific Journal of Clinical Oncology|March 7, 2018
EditorialDarren M C Poon
Lancet (London, England)|January 4, 1992
Recombinant factor VIII concentrate. The MSAC, Canadian Hemophilia Society. Canadian Hemophilia Clinic Directors GroupI Walker, M C Poon
Transfusion Medicine Reviews|October 1, 1992
International Symposium on Recombinant Factor VIII (rFVIII)M C Poon, G Growe
Canadian Journal of Biochemistry|June 1, 1975
Glutamic-pyruvic transaminase activity related to red blood cell ageC Hubert, M C Poon
Journal of Thrombosis and Haemostasis : JTH|November 20, 2004
The safety of recombinant factor VIIa: a rebuttalJ Teitel, M-C Poon
Pageof 26

Showing results (1-10 of 252) with videos related to

Sort By:
Pageof 26
Annals of Hematology|January 1, 1994
Long-term surveillance studies of previously untreated and treated patients, virally uninfected and infected patients--impact on the immune and other systemsM C Poon
Journal of the Medical Association of the State of Alabama|June 1, 1979
Evaluation of clotting disordersM C Poon
Transfusion Medicine Reviews|July 1, 1993
Cryoprecipitate: uses and alternativesM C Poon
Current Opinion in Hematology|October 18, 2001
Use of recombinant factor VIIa in hereditary bleeding disordersM C Poon
The Journal of Laboratory and Clinical Medicine|September 1, 1988
Patients with hemophilia B (Christmas disease) who have anti-factor IX: genetic heterogeneityM C Poon
Asia-Pacific Journal of Clinical Oncology|March 7, 2018
EditorialDarren M C Poon
Lancet (London, England)|January 4, 1992
Recombinant factor VIII concentrate. The MSAC, Canadian Hemophilia Society. Canadian Hemophilia Clinic Directors GroupI Walker, M C Poon
Transfusion Medicine Reviews|October 1, 1992
International Symposium on Recombinant Factor VIII (rFVIII)M C Poon, G Growe
Canadian Journal of Biochemistry|June 1, 1975
Glutamic-pyruvic transaminase activity related to red blood cell ageC Hubert, M C Poon
Journal of Thrombosis and Haemostasis : JTH|November 20, 2004
The safety of recombinant factor VIIa: a rebuttalJ Teitel, M-C Poon
Pageof 26